{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:29:02Z","timestamp":1782602942978,"version":"3.54.5"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,4,12]],"date-time":"2008-04-12T00:00:00Z","timestamp":1207958400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s12311-008-0027-y","type":"journal-article","created":{"date-parts":[[2008,5,22]],"date-time":"2008-05-22T19:26:28Z","timestamp":1211484388000},"page":"138-149","source":"Crossref","is-referenced-by-count":95,"title":["Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration"],"prefix":"10.1007","volume":"7","author":[{"given":"Gwenn A.","family":"Garden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert R.","family":"La Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,12]]},"reference":[{"key":"27_CR1","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1001\/archopht.118.10.1415","volume":"118","author":"T Abe","year":"2000","unstructured":"Abe T, Tsuda T, Yoshida M, Wada Y, Kano T, Itoyama Y, et al. Macular degeneration associated with aberrant expansion of trinucleotide repeat of the SCA7 gene in 2 Japanese families. Arch Ophthalmol. 2000;118:1415\u201321.","journal-title":"Arch Ophthalmol"},{"key":"27_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(03)00209-0","volume":"216","author":"A Bryer","year":"2003","unstructured":"Bryer A, Krause A, Bill P, Davids V, Bryant D, Butler J, et al. The hereditary adult-onset ataxias in South Africa. J Neurol Sci. 2003;216:47\u201354.","journal-title":"J Neurol Sci"},{"key":"27_CR3","first-page":"1513","volume":"57","author":"W Gu","year":"2000","unstructured":"Gu W, Wang Y, Liu X, Zhou B, Zhou Y, Wang G. Molecular and clinical study of spinocerebellar ataxia type 7 in Chinese kindreds. Arch Neurol. 2000;57:1513\u20138.","journal-title":"Arch Neurol"},{"key":"27_CR4","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s004150170072","volume":"248","author":"LB Jardim","year":"2001","unstructured":"Jardim LB, Silveira I, Pereira ML, Ferro A, Alonso I, do Ceu Moreira M, et al. A survey of spinocerebellar ataxia in South Brazil \u2013 66 new cases with Machado-Joseph disease, SCA7, SCA8, or unidentified disease-causing mutations. J Neurol. 2001;248:870\u20136.","journal-title":"J Neurol"},{"key":"27_CR5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/hmg\/7.2.171","volume":"7","author":"J Johansson","year":"1998","unstructured":"Johansson J, Forsgren L, Sandgren O, Brice A, Holmgren G, Holmberg M. Expanded CAG repeats in Swedish spinocerebellar ataxia type 7 (SCA7) patients: Effect of CAG repeat length on the clinical manifestation. Hum Mol Genet. 1998;7:171\u20136.","journal-title":"Hum Mol Genet"},{"key":"27_CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/1096-8628(20001211)95:4<351::AID-AJMG10>3.0.CO;2-R","volume":"95","author":"E Storey","year":"2000","unstructured":"Storey E, du Sart D, Shaw JH, Lorentzos P, Kelly L, McKinley Gardner RJ, et al. Frequency of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Australian patients with spinocerebellar ataxia. Am J Med Genet. 2000;95:351\u20137.","journal-title":"Am J Med Genet"},{"key":"27_CR7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/378403a0","volume":"378","author":"Y Trottier","year":"1995","unstructured":"Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, et al. Polyglutamine expansion as a pathological epitope in Huntington\u2019s disease and four dominant cerebellar ataxias. Nature. 1995;378:403\u20136.","journal-title":"Nature"},{"key":"27_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ng0997-65","volume":"17","author":"G David","year":"1997","unstructured":"David G, Abbas N, Stevanin G, Durr A, Yvert G, Cancel G, et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet. 1997;17:65\u201370.","journal-title":"Nat Genet"},{"key":"27_CR9","volume-title":"Spinocerebellar ataxia type 7: Clinical features to cellular pathogenesis. Genetic instabilities and hereditary neurological diseases","author":"GA Garden","year":"1996","unstructured":"Garden GA, Truant R, Ellerby LM, La Spada AR. Spinocerebellar ataxia type 7: Clinical features to cellular pathogenesis. Genetic instabilities and hereditary neurological diseases. San Diego, CA: Academic Press. 1996."},{"key":"27_CR10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ng0595-84","volume":"10","author":"A Benomar","year":"1995","unstructured":"Benomar A, Krols L, Stevanin G, Cancel G, LeGuern E, David G, et al. The gene for autosomal dominant cerebellar ataxia with pigmentary macular dystrophy maps to chromosome 3p12-p21.1. Nat Genet. 1995;10:84\u20138.","journal-title":"Nat Genet"},{"key":"27_CR11","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/hmg\/4.8.1441","volume":"4","author":"M Holmberg","year":"1995","unstructured":"Holmberg M, Johansson J, Forsgren L, Heijbel J, Sandgren O, Holmgren G. Localization of autosomal dominant cerebellar ataxia associated with retinal degeneration and anticipation to chromosome 3p12-p21.1. Hum Mol Genet. 1995;4:1441\u20135.","journal-title":"Hum Mol Genet"},{"key":"27_CR12","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/WNL.51.4.1081","volume":"51","author":"CS Benton","year":"1998","unstructured":"Benton CS, de Silva R, Rutledge SL, Bohlega S, Ashizawa T, Zoghbi HY. Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype. Neurology. 1998;51:1081\u20136.","journal-title":"Neurology"},{"key":"27_CR13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/hmg\/7.2.165","volume":"7","author":"G David","year":"1998","unstructured":"David G, Durr A, Stevanin G, Cancel G, Abbas N, Benomar A, et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum Mol Genet. 1998;7:165\u201370.","journal-title":"Hum Mol Genet"},{"key":"27_CR14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(83)92879-9","volume":"1","author":"AE Harding","year":"1983","unstructured":"Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet. 1983;1:1151\u20135.","journal-title":"Lancet"},{"key":"27_CR15","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1086\/302406","volume":"64","author":"P Giunti","year":"1999","unstructured":"Giunti P, Stevanin G, Worth PF, David G, Brice A, Wood NW. Molecular and clinical study of 18 families with ADCA type II: evidence for genetic heterogeneity and de novo mutation. Am J Hum Genet. 1999;64:1594\u2013603.","journal-title":"Am J Hum Genet"},{"key":"27_CR16","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/archneur.60.11.1566","volume":"60","author":"OY Bang","year":"2003","unstructured":"Bang OY, Huh K, Lee PH, Kim HJ. Clinical and neuroradiological features of patients with spinocerebellar ataxias from Korean kindreds. Arch Neurol. 2003;60:1566\u201374.","journal-title":"Arch Neurol"},{"key":"27_CR17","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/jnnp.2003.029819","volume":"75","author":"OY Bang","year":"2004","unstructured":"Bang OY, Lee PH, Kim SY, Kim HJ, Huh K. Pontine atrophy precedes cerebellar degeneration in spinocerebellar ataxia 7: MRI-based volumetric analysis. J Neurol Neurosurg Psychiatry. 2004;75:1452\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"27_CR18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00310370","volume":"88","author":"JJ Martin","year":"1994","unstructured":"Martin JJ, Van Regemorter N, Krols L, Brucher JM, de Barsy T, Szliwowski H, et al. On an autosomal dominant form of retinal-cerebellar degeneration: an autopsy study of five patients in one family. Acta Neuropathol (Berl). 1994;88:277\u201386.","journal-title":"Acta Neuropathol (Berl)"},{"key":"27_CR19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.ejhg.5201108","volume":"12","author":"A Michalik","year":"2004","unstructured":"Michalik A, Martin JJ, Van Broeckhoven C. Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy. Eur J Hum Genet. 2004;12:2\u201315.","journal-title":"Eur J Hum Genet"},{"key":"27_CR20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-510X(99)00176-8","volume":"168","author":"J Martin","year":"1999","unstructured":"Martin J, Van Regemorter N, Del-Favero J, Lofgren A, Van Broeckhoven C. Spinocerebellar ataxia type 7 (SCA7) - correlations between phenotype and genotype in one large Belgian family. J Neurol Sci. 1999;168:37\u201346.","journal-title":"J Neurol Sci"},{"key":"27_CR21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/hmg\/7.5.913","volume":"7","author":"M Holmberg","year":"1998","unstructured":"Holmberg M, Duyckaerts C, Durr A, Cancel G, Gourfinkel-An I, Damier P, et al. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet. 1998;7:913\u20138.","journal-title":"Hum Mol Genet"},{"key":"27_CR22","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/brain\/awf154","volume":"125","author":"J Takahashi","year":"2002","unstructured":"Takahashi J, Fujigasaki H, Zander C, El Hachimi KH, Stevanin G, Durr A, et al. Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content. Brain. 2002;125:1534\u201343.","journal-title":"Brain"},{"key":"27_CR23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s100480000100","volume":"3","author":"DD Einum","year":"2001","unstructured":"Einum DD, Townsend JJ, Ptacek LJ, Fu YH. Ataxin-7 expression analysis in controls and spinocerebellar ataxia type 7 patients. Neurogenetics. 2001;3:83\u201390.","journal-title":"Neurogenetics"},{"key":"27_CR24","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1523\/JNEUROSCI.22-12-04897.2002","volume":"22","author":"GA Garden","year":"2002","unstructured":"Garden GA, Libby RT, Fu YH, Kinoshita Y, Huang J, Possin DE, et al. Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice. J Neurosci. 2002;22:4897\u2013905.","journal-title":"J Neurosci"},{"key":"27_CR25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0896-6273(01)00422-6","volume":"31","author":"AR La Spada","year":"2001","unstructured":"La Spada AR, Fu Y, Sopher BL, Libby RT, Wang X, Li LY, et al. Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron. 2001;31:913\u201327.","journal-title":"Neuron"},{"key":"27_CR26","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/hmg\/10.16.1679","volume":"10","author":"G Yvert","year":"2001","unstructured":"Yvert G, Lindenberg KS, Devys D, Helmlinger D, Landwehrmeyer GB, Mandel JL. SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types. Hum Mol Genet. 2001;10:1679\u201392.","journal-title":"Hum Mol Genet"},{"key":"27_CR27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1750-3639.2000.tb00270.x","volume":"10","author":"KS Lindenberg","year":"2000","unstructured":"Lindenberg KS, Yvert G, Muller K, Landwehrmeyer GB. Expression analysis of ataxin-7 mRNA and protein in human brain: Evidence for a widespread distribution and focal protein accumulation. Brain Pathol. 2000;10:385\u201394.","journal-title":"Brain Pathol"},{"key":"27_CR28","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1073\/pnas.91.12.5355","volume":"91","author":"MF Perutz","year":"1994","unstructured":"Perutz MF, Johnson T, Suzuki M, Finch JT. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci USA. 1994;91:5355\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"27_CR29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 1997;90:537\u201348.","journal-title":"Cell"},{"key":"27_CR30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-6273(00)80943-5","volume":"19","author":"HL Paulson","year":"1997","unstructured":"Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 1997;19:333\u201344.","journal-title":"Neuron"},{"key":"27_CR31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004;431:805\u201310.","journal-title":"Nature"},{"key":"27_CR32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","volume":"421","author":"I Sanchez","year":"2003","unstructured":"Sanchez I, Mahlke C, Yuan J. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature. 2003;421:373\u20139.","journal-title":"Nature"},{"key":"27_CR33","doi-asserted-by":"crossref","first-page":"41032","DOI":"10.1074\/jbc.M205809200","volume":"277","author":"MA Poirier","year":"2002","unstructured":"Poirier MA, Li H, Macosko J, Cai S, Amzel M, Ross CA. Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization. J Biol Chem. 2002;277:41032\u20137.","journal-title":"J Biol Chem"},{"key":"27_CR34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ana.410440216","volume":"44","author":"M Li","year":"1998","unstructured":"Li M, Miwa S, Kobayashi Y, Merry DE, Yamamoto M, Tanaka F, et al. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol. 1998;44:249\u201354.","journal-title":"Ann Neurol"},{"key":"27_CR35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","volume":"8","author":"G Schilling","year":"1999","unstructured":"Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA, et al. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet. 1999;8:397\u2013407.","journal-title":"Hum Mol Genet"},{"key":"27_CR36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0896-6273(00)80839-9","volume":"24","author":"G Schilling","year":"1999","unstructured":"Schilling G, Wood JD, Duan K, Slunt HH, Gonzales V, Yamada M, et al. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA. Neuron. 1999;24:275\u201386.","journal-title":"Neuron"},{"key":"27_CR37","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","volume":"22","author":"J Gafni","year":"2002","unstructured":"Gafni J, Ellerby LM. Calpain activation in Huntington\u2019s disease. J Neurosci. 2002;22:4842\u20139.","journal-title":"J Neurosci"},{"key":"27_CR38","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ng0896-442","volume":"13","author":"YP Goldberg","year":"1996","unstructured":"Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK, et al. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet. 1996;13:442\u20139.","journal-title":"Nat Genet"},{"key":"27_CR39","doi-asserted-by":"crossref","first-page":"12784","DOI":"10.1073\/pnas.221451398","volume":"98","author":"YJ Kim","year":"2001","unstructured":"Kim YJ, Yi Y, Sapp E, Wang Y, Cuiffo B, Kegel KB, et al. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington\u2019s disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci USA. 2001;98:12784\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"27_CR40","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1074\/jbc.273.15.9158","volume":"273","author":"CL Wellington","year":"1998","unstructured":"Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, Singaraja R, et al. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem. 1998;273:9158\u201367.","journal-title":"J Biol Chem"},{"key":"27_CR41","doi-asserted-by":"crossref","first-page":"19831","DOI":"10.1074\/jbc.M001475200","volume":"275","author":"CL Wellington","year":"2000","unstructured":"Wellington CL, Singaraja R, Ellerby L, Savill J, Roy S, Leavitt B, et al. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J Biol Chem. 2000;275:19831\u20138.","journal-title":"J Biol Chem"},{"key":"27_CR42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1471-4159.1999.0720185.x","volume":"72","author":"LM Ellerby","year":"1999","unstructured":"Ellerby LM, Hackam AS, Propp SS, Ellerby HM, Rabizadeh S, Cashman NR, et al. Kennedy\u2019s disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity. J Neurochem. 1999;72:185\u201395.","journal-title":"J Neurochem"},{"key":"27_CR43","doi-asserted-by":"crossref","unstructured":"Young JE, Gouw LG, Propp SS, Lin A, Hermel E, Logvinova A, et al. Proteolytic cleavage of ataxin-7 by caspase-7 modulates cellular toxicity and transcriptional dysregulation. J Biol Chem. 2007; in press.","DOI":"10.1074\/jbc.M705265200"},{"key":"27_CR44","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1074\/jbc.M506751200","volume":"281","author":"J Taylor","year":"2006","unstructured":"Taylor J, Grote SK, Xia J, Vandelft M, Graczyk J, Ellerby LM, et al. Ataxin-7 can export from the nucleus via a conserved exportin-dependent signal. J Biol Chem. 2006;281:2730\u20139.","journal-title":"J Biol Chem"},{"key":"27_CR45","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/hmg\/ddi064","volume":"14","author":"AB Bowman","year":"2005","unstructured":"Bowman AB, Yoo SY, Dantuma NP, Zoghbi HY. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum Mol Genet. 2005;14:679\u201391.","journal-title":"Hum Mol Genet"},{"key":"27_CR46","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cellsig.2005.05.024","volume":"18","author":"HL Wang","year":"2006","unstructured":"Wang HL, Yeh TH, Chou AH, Kuo YL, Luo LJ, He CY, et al. Polyglutamine-expanded ataxin-7 activates mitochondrial apoptotic pathway of cerebellar neurons by upregulating Bax and downregulating Bcl-x(L). Cell Signal. 2006;18:541\u201352.","journal-title":"Cell Signal"},{"key":"27_CR47","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/nn1750","volume":"9","author":"SK Custer","year":"2006","unstructured":"Custer SK, Garden GA, Gill N, Rueb U, Libby RT, Schultz C, et al. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat Neurosci. 2006;9:1302\u201311.","journal-title":"Nat Neurosci"},{"key":"27_CR48","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0896-6273(02)01190-X","volume":"37","author":"SY Yoo","year":"2003","unstructured":"Yoo SY, Pennesi ME, Weeber EJ, Xu B, Atkinson R, Chen S, et al. SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity. Neuron. 2003;37:383\u2013401.","journal-title":"Neuron"},{"key":"27_CR49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/ddh005","volume":"13","author":"S Chen","year":"2004","unstructured":"Chen S, Peng GH, Wang X, Smith AC, Grote SK, Sopher BL, et al. Interference of Crx-dependent transcription by ataxin-7 involves interaction between the glutamine regions and requires the ataxin-7 carboxy-terminal region for nuclear localization. Hum Mol Genet. 2004;13:53\u201367.","journal-title":"Hum Mol Genet"},{"key":"27_CR50","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/hmg\/8.9.1657","volume":"8","author":"MD Kaytor","year":"1999","unstructured":"Kaytor MD, Duvick LA, Skinner PJ, Koob MD, Ranum LP, Orr HT. Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7. Hum Mol Genet. 1999;8:1657\u201364.","journal-title":"Hum Mol Genet"},{"issue":"Pt 12","key":"27_CR51","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1093\/brain\/123.12.2519","volume":"123","author":"G Cancel","year":"2000","unstructured":"Cancel G, Duyckaerts C, Holmberg M, Zander C, Yvert G, Lebre AS, et al. Distribution of ataxin-7 in normal human brain and retina. Brain. 2000;123(Pt 12):2519\u201330.","journal-title":"Brain"},{"key":"27_CR52","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00412-005-0329-5","volume":"113","author":"E Blazek","year":"2005","unstructured":"Blazek E, Mittler G, Meisterernst M. The mediator of RNA polymerase II. Chromosoma. 2005;113:399\u2013408.","journal-title":"Chromosoma"},{"key":"27_CR53","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.febslet.2004.11.031","volume":"579","author":"JW Conaway","year":"2005","unstructured":"Conaway JW, Florens L, Sato S, Tomomori-Sato C, Parmely TJ, Yao T, et al. The mammalian Mediator complex. FEBS Lett. 2005;579:904\u20138.","journal-title":"FEBS Lett"},{"key":"27_CR54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tibs.2004.11.007","volume":"30","author":"HT Timmers","year":"2005","unstructured":"Timmers HT, Tora L. SAGA unveiled. Trends Biochem Sci. 2005;30:7\u201310.","journal-title":"Trends Biochem Sci"},{"key":"27_CR55","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1128\/MCB.22.13.4723-4738.2002","volume":"22","author":"SL Sanders","year":"2002","unstructured":"Sanders SL, Jennings J, Canutescu A, Link AJ, Weil PA. Proteomics of the eukaryotic transcription machinery: Identification of proteins associated with components of yeast TFIID by multidimensional mass spectrometry. Mol Cell Biol. 2002;22:4723\u201338.","journal-title":"Mol Cell Biol"},{"key":"27_CR56","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1073\/pnas.0503493102","volume":"102","author":"SJ McMahon","year":"2005","unstructured":"McMahon SJ, Pray-Grant MG, Schieltz D, Yates JR, 3rd, Grant PA. Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity. Proc Natl Acad Sci USA. 2005;102:8478\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"27_CR57","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/hmg\/ddh139","volume":"13","author":"D Helmlinger","year":"2004","unstructured":"Helmlinger D, Hardy S, Sasorith S, Klein F, Robert F, Weber C, et al. Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes. Hum Mol Genet. 2004;13:1257\u201365.","journal-title":"Hum Mol Genet"},{"key":"27_CR58","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1073\/pnas.0503505102","volume":"102","author":"VB Palhan","year":"2005","unstructured":"Palhan VB, Chen S, Peng GH, Tjernberg A, Gamper AM, Fan Y, et al. Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. Proc Natl Acad Sci USA. 2005;102:8472\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"27_CR59","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.1128\/MCB.21.20.6782-6795.2001","volume":"21","author":"E Martinez","year":"2001","unstructured":"Martinez E, Palhan VB, Tjernberg A, Lymar ES, Gamper AM, Kundu TK, et al. Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo. Mol Cell Biol. 2001;21:6782\u201395.","journal-title":"Mol Cell Biol"},{"key":"27_CR60","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1371\/journal.pbio.0040067","volume":"4","author":"D Helmlinger","year":"2006","unstructured":"Helmlinger D, Hardy S, Abou-Sleymane G, Eberlin A, Bowman AB, Gansmuller A, et al. Glutamine-expanded ataxin-7 alters TFTC\/STAGA recruitment and chromatin structure leading to photoreceptor dysfunction. PLoS Biol. 2006;4:e67.","journal-title":"PLoS Biol"},{"key":"27_CR61","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.nbd.2005.04.018","volume":"20","author":"AL Strom","year":"2005","unstructured":"Strom AL, Forsgren L, Holmberg M. A role for both wildtype and expanded ataxin-7 in transcriptional regulation. Neurobiol Dis. 2005;20:646\u201355.","journal-title":"Neurobiol Dis"},{"key":"27_CR62","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","volume":"296","author":"AW Dunah","year":"2002","unstructured":"Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, Hersch SM, et al. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington\u2019s disease. Science. 2002;296:2238\u201343.","journal-title":"Science"},{"key":"27_CR63","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr","year":"2001","unstructured":"Nucifora FC, Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science. 2001;291:2423\u20138.","journal-title":"Science"},{"key":"27_CR64","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, et al. Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet. 2003;35:76\u201383.","journal-title":"Nat Genet"},{"key":"27_CR65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0092-8674(01)00630-4","volume":"108","author":"S Zhang","year":"2002","unstructured":"Zhang S, Xu L, Lee J, Xu T. Drosophila atrophin homolog functions as a transcriptional corepressor in multiple developmental processes. Cell. 2002;108:45\u201356.","journal-title":"Cell"},{"key":"27_CR66","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0896-6273(02)00697-9","volume":"34","author":"H Okazawa","year":"2002","unstructured":"Okazawa H, Rich T, Chang A, Lin X, Waragai M, Kajikawa M, et al. Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron. 2002;34:701\u201313.","journal-title":"Neuron"},{"key":"27_CR67","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1073\/pnas.0400615101","volume":"101","author":"CC Tsai","year":"2004","unstructured":"Tsai CC, Kao HY, Mitzutani A, Banayo E, Rajan H, McKeown M, et al. Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors. Proc Natl Acad Sci USA. 2004;101:4047\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"27_CR68","doi-asserted-by":"crossref","first-page":"45004","DOI":"10.1074\/jbc.M205259200","volume":"277","author":"F Li","year":"2002","unstructured":"Li F, Macfarlan T, Pittman RN, Chakravarti D. Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J Biol Chem. 2002;277:45004\u201312.","journal-title":"J Biol Chem"},{"key":"27_CR69","doi-asserted-by":"crossref","first-page":"11474","DOI":"10.1523\/JNEUROSCI.2053-06.2006","volume":"26","author":"BO Evert","year":"2006","unstructured":"Evert BO, Araujo J, Vieira-Saecker AM, de Vos RA, Harendza S, Klockgether T, et al. Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation. J Neurosci. 2006;26:11474\u201386.","journal-title":"J Neurosci"},{"key":"27_CR70","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/72101","volume":"3","author":"X Lin","year":"2000","unstructured":"Lin X, Antalffy B, Kang D, Orr HT, Zoghbi HY. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat Neurosci. 2000;3:157\u201363.","journal-title":"Nat Neurosci"},{"key":"27_CR71","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","volume":"9","author":"R Luthi-Carter","year":"2000","unstructured":"Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR, Menon AS, et al. Decreased expression of striatal signaling genes in a mouse model of Huntington\u2019s disease. Hum Mol Genet. 2000;9:1259\u201371.","journal-title":"Hum Mol Genet"},{"key":"27_CR72","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0896-6273(03)00328-3","volume":"38","author":"AR La Spada","year":"2003","unstructured":"La Spada AR, Taylor JP. Polyglutamines placed into context. Neuron. 2003;38:681\u20134.","journal-title":"Neuron"},{"key":"27_CR73","doi-asserted-by":"crossref","first-page":"13201","DOI":"10.1073\/pnas.191498198","volume":"98","author":"RE Hughes","year":"2001","unstructured":"Hughes RE, Lo RS, Davis C, Strand AD, Neal CL, Olson JM, et al. Altered transcription in yeast expressing expanded polyglutamine. Proc Natl Acad Sci USA. 2001;98:13201\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"27_CR74","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/hmg\/9.17.2491","volume":"9","author":"G Yvert","year":"2000","unstructured":"Yvert G, Lindenberg KS, Picaud S, Landwehrmeyer GB, Sahel JA, Mandel JL. Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice. Hum Mol Genet. 2000;9:2491\u2013506.","journal-title":"Hum Mol Genet"},{"key":"27_CR75","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/j.1460-2075.1996.tb00467.x","volume":"15","author":"M Fischer","year":"1996","unstructured":"Fischer M, Rulicke T, Raeber A, Sailer A, Moser M, Oesch B, et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. Embo J. 1996;15:1255\u201364.","journal-title":"Embo J"},{"key":"27_CR76","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jnnp.73.4.450","volume":"73","author":"S Koyano","year":"2002","unstructured":"Koyano S, Iwabuchi K, Yagishita S, Kuroiwa Y, Uchihara T. Paradoxical absence of nuclear inclusion in cerebellar Purkinje cells of hereditary ataxias linked to CAG expansion. J Neurol Neurosurg Psychiatry. 2002;73:450\u20132.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"27_CR77","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1023\/A:1020742404945","volume":"23","author":"JC Strahlendorf","year":"1998","unstructured":"Strahlendorf JC, Brandon T, Miles R, Strahlendorf HK. AMPA receptor-mediated alterations of intracellular calcium homeostasis in rat cerebellar Purkinje cells in vitro: Correlates to dark cell degeneration. Neurochem Res. 1998;23:1355\u201362.","journal-title":"Neurochem Res"},{"key":"27_CR78","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1523\/JNEUROSCI.15-06-04515.1995","volume":"15","author":"JR Brorson","year":"1995","unstructured":"Brorson JR, Manzolillo PA, Gibbons SJ, Miller RJ. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J Neurosci. 1995;15:4515\u201324.","journal-title":"J Neurosci"},{"key":"27_CR79","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","volume":"433","author":"JD Rothstein","year":"2005","unstructured":"Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature. 2005;433:73\u20137.","journal-title":"Nature"},{"key":"27_CR80","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nm1076","volume":"10","author":"H Xia","year":"2004","unstructured":"Xia H, Mao Q, Eliason SL, Harper SQ, Martins IH, Orr HT, et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med. 2004;10:816\u201320.","journal-title":"Nat Med"},{"key":"27_CR81","doi-asserted-by":"crossref","first-page":"9092","DOI":"10.1073\/pnas.92.20.9092","volume":"92","author":"HT Mount","year":"1995","unstructured":"Mount HT, Dean DO, Alberch J, Dreyfus CF, Black IB. Glial cell line-derived neurotrophic factor promotes the survival and morphologic differentiation of Purkinje cells. Proc Natl Acad Sci USA. 1995;92:9092\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"27_CR82","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/exnr.1994.1091","volume":"127","author":"JE Springer","year":"1994","unstructured":"Springer JE, Mu X, Bergmann LW, Trojanowski JQ. Expression of GDNF mRNA in rat and human nervous tissue. Exp Neurol. 1994;127:167\u201370.","journal-title":"Exp Neurol"},{"key":"27_CR83","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0361-9230(01)00775-4","volume":"57","author":"J Alberch","year":"2002","unstructured":"Alberch J, Perez-Navarro E, Canals JM. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington\u2019s disease. Brain Res Bull. 2002;57:817\u201322.","journal-title":"Brain Res Bull"},{"key":"27_CR84","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1097\/00001756-200012180-00032","volume":"11","author":"C Bonde","year":"2000","unstructured":"Bonde C, Kristensen BW, Blaabjerg M, Johansen TE, Zimmer J, Meyer M. GDNF and neublastin protect against NMDA-induced excitotoxicity in hippocampal slice cultures. Neuroreport. 2000;11:4069\u201373.","journal-title":"Neuroreport"},{"key":"27_CR85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hipo.10145","volume":"14","author":"H Cheng","year":"2004","unstructured":"Cheng H, Fu YS, Guo JW. Ability of GDNF to diminish free radical production leads to protection against kainate-induced excitotoxicity in hippocampus. Hippocampus. 2004;14:77\u201386.","journal-title":"Hippocampus"},{"key":"27_CR86","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1046\/j.1471-4159.2001.00538.x","volume":"78","author":"E Gratacos","year":"2001","unstructured":"Gratacos E, Perez-Navarro E, Tolosa E, Arenas E, Alberch J. Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members. J Neurochem. 2001;78:1287\u201396.","journal-title":"J Neurochem"},{"key":"27_CR87","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0014-4886(03)00172-9","volume":"183","author":"DL Tolbert","year":"2003","unstructured":"Tolbert DL, Clark BR. GDNF and IGF-I trophic factors delay hereditary Purkinje cell degeneration and the progression of gait ataxia. Exp Neurol. 2003;183:205\u201319.","journal-title":"Exp Neurol"},{"key":"27_CR88","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/exnr.2001.7718","volume":"170","author":"DL Tolbert","year":"2001","unstructured":"Tolbert DL, Bradley MW, Tolod EG, Torres-Aleman I, Clark BR. Chronic intraventricular infusion of glial cell linederived neurotrophic factor (GDNF) rescues some cerebellar Purkinje cells from heredodegeneration. Exp Neurol. 2001;170:375\u20139.","journal-title":"Exp Neurol"},{"key":"27_CR89","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/jnr.490360504","volume":"36","author":"MP Nieto-Bona","year":"1993","unstructured":"Nieto-Bona MP, Garcia-Segura LM, Torres-Aleman I. Orthograde transport and release of insulin-like growth factor I from the inferior olive to the cerebellum. J Neurosci Res. 1993;36:520\u20137.","journal-title":"J Neurosci Res"},{"key":"27_CR90","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-3940(92)90429-B","volume":"135","author":"F Aguado","year":"1992","unstructured":"Aguado F, Sanchez-Franco F, Cacidedo L, Fernandez T, Rodrigo J, Martinez-Murillo R. Subcellular localization of insulin-like growth factor I (IGF-I) in Purkinje cells of the adult rat: An immunocytochemical study. Neurosci Lett. 1992;135:171\u20134.","journal-title":"Neurosci Lett"},{"key":"27_CR91","doi-asserted-by":"crossref","first-page":"9855","DOI":"10.1073\/pnas.0403172101","volume":"101","author":"M Digicaylioglu","year":"2004","unstructured":"Digicaylioglu M, Garden G, Timberlake S, Fletcher L, Lipton SA. Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I. Proc Natl Acad Sci USA. 2004;101:9855\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"27_CR92","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/00001756-200410050-00022","volume":"15","author":"C Escartin","year":"2004","unstructured":"Escartin C, Boyer F, Bemelmans AP, Hantraye P, Brouillet E. Insulin growth factor-1 protects against excitotoxicity in the rat striatum. Neuroreport. 2004;15:2251\u20134.","journal-title":"Neuroreport"},{"key":"27_CR93","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","volume":"301","author":"BK Kaspar","year":"2003","unstructured":"Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science. 2003;301:839\u201342.","journal-title":"Science"},{"key":"27_CR94","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/exnr.1996.0053","volume":"138","author":"N Nakao","year":"1996","unstructured":"Nakao N, Odin P, Lindvall O, Brundin P. Differential trophic effects of basic fibroblast growth factor, insulin-like growth factor-1, and neurotrophin-3 on striatal neurons in culture. Exp Neurol. 1996;138:144\u201357.","journal-title":"Exp Neurol"},{"key":"27_CR95","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0197-0186(01)00106-1","volume":"40","author":"C Gamboa","year":"2002","unstructured":"Gamboa C, Ortega A. Insulin-like growth factor-1 increases activity and surface levels of the GLAST subtype of glutamate transporter. Neurochem Int. 2002;40:397\u2013403.","journal-title":"Neurochem Int"},{"key":"27_CR96","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1046\/j.1460-9568.1999.00623.x","volume":"11","author":"AM Fernandez","year":"1999","unstructured":"Fernandez AM, Gonzalez de la Vega AG, Planas B, Torres-Aleman I. Neuroprotective actions of peripherally administered insulin-like growth factor I in the injured livocerebellar pathway. Eur J Neurosci. 1999;11:2019\u201330.","journal-title":"Eur J Neurosci"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-008-0027-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12311-008-0027-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-008-0027-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:53:48Z","timestamp":1559447628000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12311-008-0027-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,12]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["27"],"URL":"https:\/\/doi.org\/10.1007\/s12311-008-0027-y","relation":{},"ISSN":["1473-4222","1473-4230"],"issn-type":[{"value":"1473-4222","type":"print"},{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,12]]}}}